Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1993
08/24/1993US5238940 Compositions for photodynamic therapy
08/24/1993US5238933 Skin permeation enhancer compositions
08/24/1993US5238927 Hydrolytic stabilizer for unstable organic ions
08/24/1993US5238920 Pulmonary surfactant protein fragments
08/24/1993US5238917 High-absorbable transvaginal preparation containing biologically active polypeptide
08/24/1993US5238714 Efficient microcapsule preparation and method of use
08/24/1993US5238688 Method for preparing a powdered particulate composition
08/24/1993US5238679 Diorganopolysiloxane dosage forms for the controlled release of iodine values
08/24/1993CA1321582C Disulfur analogs of ll-e33288 antitumor agents
08/24/1993CA1321577C Covalently bonded active agents with carbonium ion base groups
08/24/1993CA1321463C Sodium chloride in novel crystal form and aqueous solution containing the same
08/19/1993WO1993016176A1 Immobilization of chemical species in crosslinked matrices
08/19/1993WO1993016111A1 Mitogen-free substance, its preparation and its use
08/19/1993WO1993015846A1 Process and device for low-emission spraying
08/19/1993WO1993015768A1 Use of fullerenes in diagnostic and/or therapeutic agents
08/19/1993WO1993015766A1 Desensitization to specific allergens
08/19/1993WO1993015761A1 Malaria treatments
08/19/1993WO1993015760A1 Dual carrier immunogenic construct
08/19/1993WO1993015751A1 CHIMERIC TOXINS BINDING TO THE GnRH RECEPTOR
08/19/1993WO1993015747A1 A method of using cd4-containing molecules to substantially reduce the risk of occupational hiv transmission
08/19/1993WO1993015737A1 Compositions for nasal administration containing polar metabolites of opioid analgesics
08/19/1993WO1993015736A1 Dry compositions for preparing submicron emulsions
08/19/1993WO1993015725A1 Compositions and processes for the sustained release of drugs
08/19/1993WO1993015720A1 Inhibition of aggregation of drug containing particles
08/19/1993WO1993015708A1 Cosmetic and/or pharmaceutical composition containing a dispersion of lipidic vesicles, process for the preparation of said dispersion, and lipidic vesicle dispersion
08/19/1993DE4204012A1 Mitogenfreie substanz, deren herstellung und verwendung Mitogen-free substance, their preparation and use
08/19/1993CA2130357A1 Dry compositions for preparing submicron emulsions
08/19/1993CA2129754A1 Compositions and processes for the sustained release of drugs
08/18/1993EP0556110A1 Vector for therapeutic or cosmetic drugs for external use and therapeutic or cosmetic composition containing such a vector
08/18/1993EP0556096A1 Composition for stabilizing bloodplasma during pasteurization and pasteurized plasma solution for therapeutic use
08/18/1993EP0555898A2 Medicaments for non-topical use
08/18/1993EP0555693A1 Method of producing highly watersoluble cyclodextrin complex
08/18/1993EP0555427A1 Bioactive composition
08/18/1993EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity
08/18/1993EP0555385A1 Agents and methods for binding to elam-1
08/18/1993EP0555360A1 Transdermal contraceptive formulations, methods and devices
08/18/1993EP0555317A1 Phospholipid analogue vesicle with a succinimidyl moiety.
08/18/1993EP0555309A1 Topical composition with retinoid penetration enhancer
08/18/1993EP0493485A4 Erection-inducing methods and compositions
08/18/1993EP0479777B1 Spironolactone composition
08/18/1993EP0262178B1 Amino acid chelated compositions for delivery to specific biological tissue sites
08/18/1993CN1075253A Compositions and processes for the sustained release of drugs
08/18/1993CA2086989A1 Dosage forms having prolonged active ingredient release
08/17/1993US5237050 Bacterial plasmin receptors as fibrinolytic agents
08/17/1993US5236966 Polymeric materials
08/17/1993US5236906 Adrenocortical hormone and hyaluronic acid; skin diseases
08/17/1993US5236904 Erection-inducing methods and compositions
08/17/1993US5236714 Administering abuse substance in permeable form in conjunction with an antagonist in impermeable form; eliminates immediate "high" without diminishing therapeutic value
08/17/1993US5236707 Primary alkylamine; storage stability
08/17/1993US5236704 Controlled release formulation
08/17/1993CA1321393C Besylate salt of amlodipine
08/17/1993CA1321347C Human leukocyte interferon composition and skin treatment
08/11/1993EP0554898A2 Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
08/11/1993EP0554708A1 Thioether conjugates
08/11/1993EP0554634A1 Stabilized pharmaceutical composition comprising non-glycosylated, reduced, recombinant human IL-2 and process to prepare it
08/11/1993EP0554441A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
08/11/1993EP0554358A1 Chelating agents
08/11/1993EP0554356A1 A monoclonal antibody
08/11/1993EP0554352A1 A method for transplanting cells into the brain and therapeutic uses therefor
08/11/1993EP0554318A1 A solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor
08/11/1993EP0554292A1 Oil-in-water emulsions.
08/11/1993EP0478686B1 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
08/11/1993EP0406327B1 Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
08/11/1993CN1075079A Medicaments
08/11/1993CN1075078A Medicaments
08/10/1993US5235033 Alpha-morpholino ribonucleoside derivatives and polymers thereof
08/10/1993US5234992 Transdermal drug delivery
08/10/1993US5234991 Capable of fixing thereto biological macromolecules
08/10/1993US5234959 Omega-dialkylaminoalkanoic acids; drug delivery directly to the bloodstream
08/10/1993US5234949 Treatment of arrhythmias
08/10/1993US5234927 Magnesium oxide as a biodegradation retarding agent
08/10/1993US5234915 Biodegradable gel
08/10/1993US5234912 Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
08/10/1993US5234903 A deoxygenated, reduced hemoglobin conjugated to a polyoxyalkylene glycol; synthetic blood; oxygen transport; extended half-life; nontoxic
08/10/1993US5234706 Edible flour of comminuted particles containing starches, soluble fiber, insoluble fiber
08/10/1993US5234691 Encapsulated for oral administration
08/10/1993US5233995 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
08/10/1993CA1321192C Inclusion complexes of cyclodextrins by agglomeration
08/10/1993CA1321190C Method and product for increasing fertility in sheep
08/10/1993CA1321145C Pharmaceutical preparations
08/10/1993CA1321144C Pharmaceutical preparations
08/10/1993CA1321100C Process for the preparation of an antioxydant extract of spices
08/05/1993WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
08/05/1993WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine
08/05/1993WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
08/05/1993WO1993015117A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
08/05/1993WO1993015113A1 An immunotoxin including a cytotoxin with an unpaired cysteine residue in or near its receptor-binding site
08/05/1993WO1993015108A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
08/05/1993WO1993014790A1 A method for transplanting cells into the brain and therapeutic uses therefor
08/05/1993WO1993014746A1 Method and compositions for inhibiting tumor cell metabolism
08/05/1993WO1993014744A1 Non-toxic lipid vaccine formulations
08/05/1993WO1993014742A1 Water-in-oil emulsion stable in the course of time, with high silicone content
08/05/1993WO1993007905A3 Treated apatite particles for medical diagnostic imaging
08/05/1993WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
08/05/1993CA2626680A1 Peritoneal dialysis composition and method usable during and after peritonitis
08/05/1993CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor
08/05/1993CA2128630A1 A method for transplanting cells into the brain and therapeutic uses therefor
08/04/1993EP0553790A1 Cyclic amp derivative-containing ointment
08/04/1993EP0553777A2 Fast dissolving tablet and its production
08/04/1993EP0553658A2 Pharmaceutically active composition from Tanacetum partenium, process of extraction and medicinal composition
1 ... 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 ... 1712